Featured Research

from universities, journals, and other organizations

Receptor for Ebola virus identified

Date:
May 3, 2011
Source:
University of Iowa Health Care
Summary:
Researchers have identified a cellular protein that acts as a receptor for Ebola virus and Marburg virus. Furthermore, the team showed that an antibody, which binds to the receptor protein, is able to block infection by both viruses. The results suggest that a human-compatible version of the antibody might provide a way to prevent initial infection during an outbreak.

Cellular protein TIM-1 acts as a receptor for Ebola virus and Marburg virus. Microscope image shows TIM-1 expression (in green) on the surface of human airway cells.
Credit: University of Iowa

A team of researchers has identified a cellular protein that acts as a receptor for Ebola virus and Marburg virus. Furthermore, the team showed that an antibody, which binds to the receptor protein, is able to block infection by both viruses.

Related Articles


"This is the first receptor identified for Ebola and Marburg viruses," said Wendy Maury, Ph.D., associate professor of microbiology at the University of Iowa Roy J. and Lucille A. Carver College of Medicine and senior study author. "That's important because if you can identify and understand the first step in infection -- how the virus enters cells -- then perhaps you can prevent the infection by nipping it in the bud."

Ebola and Marburg viruses cause hemorrhagic fever in humans and other primates. For some strains, infection can lead to death in 50 to 90 percent of cases, and there is no cure or effective treatment. The findings are published online the week of May 2 in the Proceedings of the National Academy of Sciences Early Edition.

Maury led a multidisciplinary team that included colleagues from four UI departments as well as collaborators at the National Institute of Dental and Craniofacial Research (NIDCR) in Bethesda, Md., University of Texas Medical Branch in Galveston, Texas, and Biogen Idec, in Cambridge, Mass.

The researchers used a new bioinformatics-based approach, developed by John Chiorini at NIDCR, to identify a protein called TIM-1 as a receptor for Ebola and Marburg viruses. Subsequent experiments proved that both Ebola and Marburg viruses use TIM-1 is a receptor for infecting cells.

The study also showed that TIM-1 protein is widely expressed on epithelial cells that line various tissues in the body including mucosal surfaces of the airways and in the eyes.

Maury noted that these locations are consistent with some of the ways the Ebola virus is thought to be transmitted -- inhalation of aerosolized droplets and hand-to-eye contact.

A further collaboration with Paul Rennert, Ph.D., at Biogen Idec, a biotech company based in Cambridge, Mass., provided the team with antibodies targeted to TIM-1 and the team found that one of these antibodies, ARD5, very effectively blocks Ebola and Marburg virus entry into cells.

Finally, work performed by Robert Davey, Ph.D., in a BSL-4 lab (the highest level of biocontainment) at University of Texas Medical Branch verified that the ARD5 antibody blocks infection by infectious Zaire Ebola Virus in cells that express the TIM-1 protein.

The results suggest that being able to block Ebola's entry into epithelial cells, perhaps with a human-compatible version of the ARD5 antibody, might provide a way to prevent initial infection and potentially limit the spread of the disease during an outbreak.

Importantly, the study found that TIM-1 protein is not expressed on all the cell types that are infected by Ebola and Marburg.

"It's clear that there are other receptors for Ebola because while TIM-1 is found on a number of epithelial cells in the body, it is not found on some important cell types that are infected by Ebola," Maury said. "Ultimately, epithelial cells are not as important a target for the virus as some other cell types, but they may be the first entry point for Ebola, so they may provide a conduit that allows Ebola access to those other cells within the body."

The research team also included first author Andrew Kondratowicz, a UI graduate student, and UI researchers Paul McCray; Nicholas Lennemann; Patrick Sinn; Catherine Hunt; Sven Moller-Tank; David Meyerholz; Robert Mullins; Melinda Brindley and Lindsay Sanderfeld as well as Kathrina Quinn and Melodie Weller at the NIDCR.

The study was funded in part by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University of Iowa Health Care. Note: Materials may be edited for content and length.


Journal Reference:

  1. Andrew S. Kondratowicz, Nicholas J. Lennemann, Patrick L. Sinn, Robert A. Davey, Catherine L. Hunt, Sven Moller-Tank, David K. Meyerholz, Paul Rennert, Robert F. Mullins, Melinda Brindley, Lindsay M. Sandersfeld, Kathrina Quinn, Melodie Weller, Paul B. Mccray, Jr., John Chiorini, and Wendy Maury. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. PNAS, May 2, 2011 DOI: 10.1073/pnas.1019030108

Cite This Page:

University of Iowa Health Care. "Receptor for Ebola virus identified." ScienceDaily. ScienceDaily, 3 May 2011. <www.sciencedaily.com/releases/2011/05/110502151349.htm>.
University of Iowa Health Care. (2011, May 3). Receptor for Ebola virus identified. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/05/110502151349.htm
University of Iowa Health Care. "Receptor for Ebola virus identified." ScienceDaily. www.sciencedaily.com/releases/2011/05/110502151349.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins